Package 31722-440-30

Brand: avanafil

Generic: avanafil
NDC Package

Package Facts

Identity

Package NDC 31722-440-30
Digits Only 3172244030
Product NDC 31722-440
Description

30 TABLET in 1 BOTTLE (31722-440-30)

Marketing

Marketing Status
Marketed Since 2024-06-14
Brand avanafil
Generic avanafil
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "46258a47-8730-8397-e063-6394a90a6478", "openfda": {"nui": ["N0000175599", "N0000020026"], "upc": ["0331722442305", "0331722440301", "0331722441308"], "unii": ["DR5S136IVO"], "rxcui": ["1291306", "1291365", "1291369"], "spl_set_id": ["1d04e17d-7399-430a-a8bb-fa1912b155e9"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (31722-440-01)", "package_ndc": "31722-440-01", "marketing_start_date": "20240614"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (31722-440-30)", "package_ndc": "31722-440-30", "marketing_start_date": "20240614"}], "brand_name": "Avanafil", "product_id": "31722-440_46258a47-8730-8397-e063-6394a90a6478", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "31722-440", "generic_name": "Avanafil", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Avanafil", "active_ingredients": [{"name": "AVANAFIL", "strength": "50 mg/1"}], "application_number": "ANDA209266", "marketing_category": "ANDA", "marketing_start_date": "20240614", "listing_expiration_date": "20261231"}